PRA Health Sciences
PRA Health Sciences is a contract research organization with headquarters in Raleigh, North Carolina that was founded in 1982. In 2013 the company was acquired by Kohlberg Kravis Roberts, which brought the company public in November 2014 and maintained shares until September 2019.
In August 2017 the company acquired Conshohocken-based real-world healthcare data, analytics, and technology solutions company Symphony Health for US$530 million.
In November 2019 PRA announced it was partnering with Johnson & Johnson pharmaceutical arm Janssen Pharmaceutica in a first-of-its-kind decentralized clinical trial evaluating the drug Invokana in adults with heart failure, with preserved or reduced ejection fraction, with or without type 2 diabetes. This landmark study will collect real-world evidence via a mobile clinical trial platform.
PRA's 2018 revenue was US$2.87 billion.
